“Ability proceeds from a fusion of skills, knowledge, understanding and imagination, consolidated by experience.”
MICHAEL KLARKE
Avada has been the #1 selling theme for 5 years with over 350,000 satisfied customers. We will continue and produce amazing updates for our customer base.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor ins.
RECENT ARTCLES
LOREM IPSUM DOLOR SIT AMET, CONSECTETUR ADIPISICING ELIT, SED DO EIUSMOD TEMPOR INCIDIDUNT UT LABORE ET DOLORE MAGNA ALIQUA ETS UNSERS.
Comparison of Titropium Delivery with the ODAPT Adapter and a Valved Holding Chamber
Facemasks are commonly used by certain patients requiring assistance for aerosol medication delivery. Adapters are used as connectors between facemasks and inhalers. The valved holding chamber (VHC) is commonly prescribed with pressurized metered dose inhalers (pMDIs) to improve medication delivery. Recently, the VHC has been used with the Respimat Soft Mist Inhaler (SMI), which is a propellant-free inhaler. The ODAPT soft mist adapter was previously designed to serve as a connector for facemasks used with the Respimat SMI.
Respimat Soft Mist Inhaler SMI in Vitro Aerosol Delivery with the ODAPT Adapter and Facemask
The Respimat Soft Mist Inhaler (SMI) is a propellant-free inhaler that generates a fine aerosol mist suitable for inhalation. For patients requiring facemasks for medication delivery, the presence of the facemask influences the lung deposition. The purpose of this study was to assess, in vitro, the effect of the attachment of add-ons (ODAPT soft mist adapter with facemask) to the Respimat SMI on the medication delivery under different conditions and evaluate the efficacy of the ODAPT with facemask.
Mesure des dépôts d’aérosols avec l’adaptateur de masque ODAPT
L’aérosol est couramment utilisé pour administrer des médicaments thérapeutiques aux patients souffrant d’asthme et de maladies pulmonaires obstructives chroniques (MPOC). Cette étude in vitro a pour objectif de définir les effets de l’utilisation du masque facial EcoMask et de l’adaptateur ODAPT avec l’inhalateur Soft-Mist Spiriva Respimat (SMI) dans différents contextes.
Aerosol Deposition Measurements with ODAPT Mask Adapter
Aerosol is commonly used to deliver therapeutic drugs to patient suffering from asthma and chronic obstructive pulmonary disease (COPD). The purpose of this in vitro study is to characterize the effect of using the EcoMask facemask and the ODAPT adapter with the Spiriva Respimat Soft Mist Inhaler (SMI) in different environments.